Table: begin end state 1 27 signal peptide 28 257 non-cytoplasmic 258 282 transmembrane 283 284 cytoplasmic 285 305 transmembrane 306 310 non-cytoplasmic 311 334 transmembrane 335 345 cytoplasmic 346 364 transmembrane 365 397 non-cytoplasmic 398 415 transmembrane 416 443 cytoplasmic 444 464 transmembrane 465 480 non-cytoplasmic 481 505 transmembrane 506 512 cytoplasmic 513 531 transmembrane 532 548 non-cytoplasmic
Input: >WP_019864733.1 NCBI__GCF_000384075.1:WP_019864733.1 MTLFNPTRCQALLALLMLVFSLAAHSDPQPAPQPWLDALDTLKQGSMPEREKAIMQLADI KDAHNLAILQALLDSKLFITKTDARLVIGTDNHQGFDLSDAVSGASLGAVGHDALTKINL TNKMRGTLRKIIGELELSADDPKVRLAAVKAMAKEADEKAISLLRERAGQEQDEAVREAI KVALLLQDMDSEDKAVRIMAIEGLKAYDSQEAANRLNAMLEKDENGEYSEPDADVRNLAK ASLTNINNRLQLYGSIETIFFGLSLGAVLVLSAIGLAITFGVMGVINMAHGELMMLGAYT TYVIQQLMPNYLGVSVIIAIPAAFVISALAGIAIERGIIRFLYGRPLETLLATFGVSLIL QQSVRSIFSPLNRSVATPEWMSGSWQINDFLSLTWNRFYILVFCLLVFVLLLQILKRTSL GLEVRAVAQNRKMAKAMGIPTARVDAMTFGLGSGIAGVAGVALSQITNVGPNLGQAYIVD SFMVVVFGGVGNLLGTLVAGFSLGIANKFLEPFAGAVLAKILVLVFIILFIQKRPRGLFP QKGRAADS
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server